Stacia Carroll, DPT | |
800 Fair Park Blvd, Little Rock, AR 72204-1720 | |
(501) 404-8007 | |
(501) 904-3620 |
Full Name | Stacia Carroll |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 800 Fair Park Blvd, Little Rock, Arkansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063131118 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT-5186 (Arkansas) | Primary |
Provider Name | Orthoarkansas, Pa |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1952336869 PECOS PAC ID: 1456256031 Enrollment ID: O20031205000490 |
News Archive
Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a treatment approach that weighs the benefits of specific therapies against potential damage to the heart, according to a new scientific statement from the American Heart Association published in its journal Circulation.
For the purpose of improving patient safety, VTT Technical Research Centre of Finland has developed a new management model based on customer needs. All the actors taking part in the organizational activity in social and health care organizations play a key role in safety management - including the patient. Both in Finland and abroad, there is a clear need for the systematic improvement of patient safety. Patient safety cannot be improved by simply making new rules.
YM BioSciences Inc., today reported that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH).
A rapid, sensitive, and accurate method to detect drug resistant hepatitis C virus (HCV) mutants has been developed. Researchers at Hiroshima University established a system to rapidly and accurately measure the presence of HCV Y93H drug resistant mutant strains, and evaluate the proportion of patients harboring this mutation prior to treatment.
The finding suggests that tear analysis could not only be an effective means of diagnosing the infection, but also an unrecognised source of its spread, if appropriate preventive measures are not taken, say the authors.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Stacia Carroll, DPT 800 Fair Park Blvd, Little Rock, AR 72204-1720 Ph: (501) 404-8007 | Stacia Carroll, DPT 800 Fair Park Blvd, Little Rock, AR 72204-1720 Ph: (501) 404-8007 |
News Archive
Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a treatment approach that weighs the benefits of specific therapies against potential damage to the heart, according to a new scientific statement from the American Heart Association published in its journal Circulation.
For the purpose of improving patient safety, VTT Technical Research Centre of Finland has developed a new management model based on customer needs. All the actors taking part in the organizational activity in social and health care organizations play a key role in safety management - including the patient. Both in Finland and abroad, there is a clear need for the systematic improvement of patient safety. Patient safety cannot be improved by simply making new rules.
YM BioSciences Inc., today reported that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH).
A rapid, sensitive, and accurate method to detect drug resistant hepatitis C virus (HCV) mutants has been developed. Researchers at Hiroshima University established a system to rapidly and accurately measure the presence of HCV Y93H drug resistant mutant strains, and evaluate the proportion of patients harboring this mutation prior to treatment.
The finding suggests that tear analysis could not only be an effective means of diagnosing the infection, but also an unrecognised source of its spread, if appropriate preventive measures are not taken, say the authors.
› Verified 4 days ago
Patricia Hayes Swanson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1401 Labelle Dr, Little Rock, AR 72204 Phone: 501-444-2390 | |
David Richard Holmquist, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1601 Aldersgate Rd, Little Rock, AR 72205 Phone: 501-687-0851 Fax: 501-687-0853 | |
Mrs. Ginger Jones Lester, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 708 E Dixon Rd, Little Rock, AR 72206 Phone: 501-490-5837 | |
Kirk Andrew Turnbo, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 600 S Mckinley St, 1st Floor Pt Dept, Little Rock, AR 72205 Phone: 501-225-0181 | |
Sarah Olney, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 424 N University Ave, Little Rock, AR 72205 Phone: 501-661-0336 | |
United Cerebral Palsy Of Arkansas Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9720 N Rodney Parham Rd, Little Rock, AR 72227 Phone: 501-224-6067 Fax: 501-227-5591 | |
Ms. Karen T Irico, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2685 Fax: 501-202-2003 |